Literature DB >> 28636425

American Thoracic Society/National Heart, Lung, and Blood Institute Asthma-Chronic Obstructive Pulmonary Disease Overlap Workshop Report.

Prescott G Woodruff1, Maarten van den Berge2, Richard C Boucher3, Christopher Brightling4, Esteban G Burchard1, Stephanie A Christenson1, MeiLan K Han5, Michael J Holtzman6, Monica Kraft7, David A Lynch8, Fernando D Martinez9, Helen K Reddel10, Don D Sin11, George R Washko12, Sally E Wenzel13, Antonello Punturieri14, Michelle M Freemer14, Robert A Wise15.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are highly prevalent chronic obstructive lung diseases with an associated high burden of disease. Asthma, which is often allergic in origin, frequently begins in infancy or childhood with variable airflow obstruction and intermittent wheezing, cough, and dyspnea. Patients with COPD, in contrast, are usually current or former smokers who present after the age of 40 years with symptoms (often persistent) including dyspnea and a productive cough. On the basis of age and smoking history, it is often easy to distinguish between asthma and COPD. However, some patients have features compatible with both diseases. Because clinical studies typically exclude these patients, their underlying disease mechanisms and appropriate treatment remain largely uncertain. To explore the status of and opportunities for research in this area, the NHLBI, in partnership with the American Thoracic Society, convened a workshop of investigators in San Francisco, California on May 14, 2016. At the workshop, current understanding of asthma-COPD overlap was discussed among clinicians, pathologists, radiologists, epidemiologists, and investigators with expertise in asthma and COPD. They considered knowledge gaps in our understanding of asthma-COPD overlap and identified strategies and research priorities that will advance its understanding. This report summarizes those discussions.

Entities:  

Keywords:  asthma; chronic obstructive pulmonary disease; overlap

Mesh:

Year:  2017        PMID: 28636425      PMCID: PMC5549872          DOI: 10.1164/rccm.201705-0973WS

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  62 in total

1.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

2.  Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data.

Authors:  Wei Wu; Eugene Bleecker; Wendy Moore; William W Busse; Mario Castro; Kian Fan Chung; William J Calhoun; Serpil Erzurum; Benjamin Gaston; Elliot Israel; Douglas Curran-Everett; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

3.  The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma.

Authors:  Lisa G Wood; Katherine J Baines; Juanjuan Fu; Hayley A Scott; Peter G Gibson
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

4.  Effects of steroid therapy on inflammatory cell subtypes in asthma.

Authors:  Douglas C Cowan; Jan O Cowan; Rochelle Palmay; Avis Williamson; D Robin Taylor
Journal:  Thorax       Date:  2009-12-08       Impact factor: 9.139

5.  Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.

Authors:  Marco Contoli; Simonetta Baraldo; Brunilda Marku; Paolo Casolari; John A Marwick; Graziella Turato; Micaela Romagnoli; Gaetano Caramori; Marina Saetta; Leonardo M Fabbri; Alberto Papi
Journal:  J Allergy Clin Immunol       Date:  2010-03-15       Impact factor: 10.793

6.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  C E Brightling; W Monteiro; R Ward; D Parker; M D Morgan; A J Wardlaw; I D Pavord
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

7.  Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema.

Authors:  Rosa Faner; Tamara Cruz; Teresa Casserras; Alejandra López-Giraldo; Guillaume Noell; Ignacio Coca; Ruth Tal-Singer; Bruce Miller; Roberto Rodriguez-Roisin; Avrum Spira; Susana G Kalko; Alvar Agustí
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

8.  Characteristics of COPD phenotypes classified according to the findings of HRCT.

Authors:  Yoshiaki Kitaguchi; Keisaku Fujimoto; Keishi Kubo; Takayuki Honda
Journal:  Respir Med       Date:  2006-03-23       Impact factor: 3.415

9.  Genetic ancestry influences asthma susceptibility and lung function among Latinos.

Authors:  Maria Pino-Yanes; Neeta Thakur; Christopher R Gignoux; Joshua M Galanter; Lindsey A Roth; Celeste Eng; Katherine K Nishimura; Sam S Oh; Hita Vora; Scott Huntsman; Elizabeth A Nguyen; Donglei Hu; Katherine A Drake; David V Conti; Andres Moreno-Estrada; Karla Sandoval; Cheryl A Winkler; Luisa N Borrell; Fred Lurmann; Talat S Islam; Adam Davis; Harold J Farber; Kelley Meade; Pedro C Avila; Denise Serebrisky; Kirsten Bibbins-Domingo; Michael A Lenoir; Jean G Ford; Emerita Brigino-Buenaventura; William Rodriguez-Cintron; Shannon M Thyne; Saunak Sen; Jose R Rodriguez-Santana; Carlos D Bustamante; L Keoki Williams; Frank D Gilliland; W James Gauderman; Rajesh Kumar; Dara G Torgerson; Esteban G Burchard
Journal:  J Allergy Clin Immunol       Date:  2014-10-06       Impact factor: 10.793

10.  IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.

Authors:  Yael G Alevy; Anand C Patel; Arthur G Romero; Dhara A Patel; Jennifer Tucker; William T Roswit; Chantel A Miller; Richard F Heier; Derek E Byers; Tom J Brett; Michael J Holtzman
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

View more
  39 in total

1.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

Review 2.  Of pleiotropy and trajectories: Does the TGF-β pathway link childhood asthma and chronic obstructive pulmonary disease?

Authors:  Avery DeVries; Donata Vercelli
Journal:  J Allergy Clin Immunol       Date:  2018-04-27       Impact factor: 10.793

3.  Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  Jeong H Yun; Andrew Lamb; Robert Chase; Dave Singh; Margaret M Parker; Aabida Saferali; Jørgen Vestbo; Ruth Tal-Singer; Peter J Castaldi; Edwin K Silverman; Craig P Hersh
Journal:  J Allergy Clin Immunol       Date:  2018-04-28       Impact factor: 10.793

Review 4.  Interactive Roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases.

Authors:  Lan Wang; Roman G Ginnan; Yong-Xiao Wang; Yun-Min Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Compressive air trapping in asthma: effects of age, sex, and severity.

Authors:  Ronald L Sorkness; Casey Kienert; Matthew J O'Brien; Sean B Fain; Nizar N Jarjour
Journal:  J Appl Physiol (1985)       Date:  2019-03-07

Review 6.  Chronic obstructive pulmonary disease classification, phenotypes and risk assessment.

Authors:  Prasad Manian
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

7.  Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.

Authors:  Nilanjana Ghosh; Priyanka Choudhury; Elavarasan Subramani; Dipanjan Saha; Sayoni Sengupta; Mamata Joshi; Rintu Banerjee; Sushmita Roychowdhury; Parthasarathi Bhattacharyya; Koel Chaudhury
Journal:  Metabolomics       Date:  2019-06-04       Impact factor: 4.290

8.  Predictors of Asthma/COPD Overlap in FDNY Firefighters With World Trade Center Dust Exposure: A Longitudinal Study.

Authors:  Ankura Singh; Charles Liu; Barbara Putman; Rachel Zeig-Owens; Charles B Hall; Theresa Schwartz; Mayris P Webber; Hillel W Cohen; Kenneth I Berger; Anna Nolan; David J Prezant; Michael D Weiden
Journal:  Chest       Date:  2018-07-17       Impact factor: 9.410

9.  A Review of Portable Electronic Spirometers: Implications for Asthma Self-Management.

Authors:  Delesha M Carpenter; Reina Jurdi; Courtney A Roberts; Michelle Hernandez; Robert Horne; Amy Chan
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-25       Impact factor: 4.806

Review 10.  Asthma Over the Age of 65: All's Well That Ends Well.

Authors:  Alan P Baptist; Paula J Busse
Journal:  J Allergy Clin Immunol Pract       Date:  2018 May - Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.